PMC:7293470 / 1814-2101 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T67","span":{"begin":4,"end":14},"obj":"SP_7"},{"id":"T68","span":{"begin":39,"end":44},"obj":"UBERON:0000062"},{"id":"T69","span":{"begin":96,"end":111},"obj":"CHEBI:24261;CHEBI:24261"},{"id":"T70","span":{"begin":134,"end":142},"obj":"SP_7"},{"id":"T71","span":{"begin":172,"end":176},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T12505","span":{"begin":4,"end":14},"obj":"SP_7"},{"id":"T88611","span":{"begin":39,"end":44},"obj":"UBERON:0000062"},{"id":"T60848","span":{"begin":96,"end":111},"obj":"CHEBI:24261;CHEBI:24261"},{"id":"T95231","span":{"begin":134,"end":142},"obj":"SP_7"},{"id":"T65747","span":{"begin":172,"end":176},"obj":"CHEBI:23888;CHEBI:23888"}],"text":" by SARS-CoV-2, leading to fatal multi-organ failure.\nIn addition to current approaches such as glucocorticoids for treating advanced COVID-19 patients, there may be other drug combinations that could be helpful, some being bifunctional. As relevant examples reviewed in [5], pharmacolog"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T27","span":{"begin":39,"end":44},"obj":"Body_part"}],"attributes":[{"id":"A27","pred":"fma_id","subj":"T27","obj":"http://purl.org/sig/ont/fma/fma67498"}],"text":" by SARS-CoV-2, leading to fatal multi-organ failure.\nIn addition to current approaches such as glucocorticoids for treating advanced COVID-19 patients, there may be other drug combinations that could be helpful, some being bifunctional. As relevant examples reviewed in [5], pharmacolog"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T9","span":{"begin":39,"end":44},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":" by SARS-CoV-2, leading to fatal multi-organ failure.\nIn addition to current approaches such as glucocorticoids for treating advanced COVID-19 patients, there may be other drug combinations that could be helpful, some being bifunctional. As relevant examples reviewed in [5], pharmacolog"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T15","span":{"begin":4,"end":12},"obj":"Disease"},{"id":"T16","span":{"begin":4,"end":8},"obj":"Disease"},{"id":"T17","span":{"begin":33,"end":52},"obj":"Disease"},{"id":"T18","span":{"begin":134,"end":142},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0043726"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" by SARS-CoV-2, leading to fatal multi-organ failure.\nIn addition to current approaches such as glucocorticoids for treating advanced COVID-19 patients, there may be other drug combinations that could be helpful, some being bifunctional. As relevant examples reviewed in [5], pharmacolog"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T40","span":{"begin":39,"end":44},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"}],"text":" by SARS-CoV-2, leading to fatal multi-organ failure.\nIn addition to current approaches such as glucocorticoids for treating advanced COVID-19 patients, there may be other drug combinations that could be helpful, some being bifunctional. As relevant examples reviewed in [5], pharmacolog"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T23","span":{"begin":96,"end":111},"obj":"Chemical"},{"id":"T24","span":{"begin":172,"end":176},"obj":"Chemical"}],"attributes":[{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_24261"},{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":" by SARS-CoV-2, leading to fatal multi-organ failure.\nIn addition to current approaches such as glucocorticoids for treating advanced COVID-19 patients, there may be other drug combinations that could be helpful, some being bifunctional. As relevant examples reviewed in [5], pharmacolog"}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":54,"end":237},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" by SARS-CoV-2, leading to fatal multi-organ failure.\nIn addition to current approaches such as glucocorticoids for treating advanced COVID-19 patients, there may be other drug combinations that could be helpful, some being bifunctional. As relevant examples reviewed in [5], pharmacolog"}

{"project":"LitCovid-PubTator","denotations":[{"id":"63","span":{"begin":4,"end":14},"obj":"Species"},{"id":"85","span":{"begin":33,"end":52},"obj":"Disease"},{"id":"129","span":{"begin":143,"end":151},"obj":"Species"},{"id":"135","span":{"begin":134,"end":142},"obj":"Disease"}],"attributes":[{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"Tax:2697049"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"MESH:D009102"},{"id":"A129","pred":"tao:has_database_id","subj":"129","obj":"Tax:9606"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" by SARS-CoV-2, leading to fatal multi-organ failure.\nIn addition to current approaches such as glucocorticoids for treating advanced COVID-19 patients, there may be other drug combinations that could be helpful, some being bifunctional. As relevant examples reviewed in [5], pharmacolog"}